These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 26694588
1. No association between macrolide treatment in infancy and later pyloric stenosis in Sweden. Ludvigsson JF, Lundholm C, Örtqvist AK, Almqvist C. Eur J Epidemiol; 2016 Mar; 31(3):331-2. PubMed ID: 26694588 [No Abstract] [Full Text] [Related]
2. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Abdellatif M, Ghozy S, Kamel MG, Elawady SS, Ghorab MME, Attia AW, Le Huyen TT, Duy DTV, Hirayama K, Huy NT. Eur J Pediatr; 2019 Mar; 178(3):301-314. PubMed ID: 30470884 [Abstract] [Full Text] [Related]
10. The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Almaramhy HH, Al-Zalabani AH. Ital J Pediatr; 2019 Feb 04; 45(1):20. PubMed ID: 30717812 [Abstract] [Full Text] [Related]
11. Are young infants treated with erythromycin at risk for developing hypertrophic pyloric stenosis? Maheshwai N. Arch Dis Child; 2007 Mar 04; 92(3):271-3. PubMed ID: 17337692 [No Abstract] [Full Text] [Related]
12. Post-natal erythromycin exposure and risk of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Murchison L, De Coppi P, Eaton S. Pediatr Surg Int; 2016 Dec 04; 32(12):1147-1152. PubMed ID: 27655365 [Abstract] [Full Text] [Related]
14. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Morrison W. Pediatr Infect Dis J; 2007 Feb 04; 26(2):186-8. PubMed ID: 17259889 [Abstract] [Full Text] [Related]
15. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Sørensen HT, Skriver MV, Pedersen L, Larsen H, Ebbesen F, Schønheyder HC. Scand J Infect Dis; 2003 Feb 04; 35(2):104-6. PubMed ID: 12693559 [Abstract] [Full Text] [Related]
16. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. Mahon BE, Rosenman MB, Kleiman MB. J Pediatr; 2001 Sep 04; 139(3):380-4. PubMed ID: 11562617 [Abstract] [Full Text] [Related]
17. [The safety of macrolide antibiotics: critical analysis]. Sinopal'nikov AI, Andreeva IV, Stetsiuk OU. Klin Med (Mosk); 2012 Sep 04; 90(3):23-30. PubMed ID: 22690560 [Abstract] [Full Text] [Related]
18. Prescription of macrolides vs penicillin during pregnancy was linked to major malformations in offspring. Zipursky J. Ann Intern Med; 2020 Jun 16; 172(12):JC70. PubMed ID: 32539502 [Abstract] [Full Text] [Related]
19. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Hauben M, Amsden GW. Drug Saf; 2002 Jun 16; 25(13):929-42. PubMed ID: 12381214 [Abstract] [Full Text] [Related]
20. Hypertrophic pyloric stenosis of infancy associated with ulcer. A case report. LEVINE M. Arch Pediatr (N Y); 1961 Dec 16; 78():475-7. PubMed ID: 14464627 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]